
Trump Executive Order Fast-Tracks Psychedelic Therapies, Names Ibogaine for PTSD Despite Safety Concerns
Quick Answer: On April 18, 2026, President Trump signed an executive order directing the FDA to accelerate the approval of psychedelic therapies,…










